share_log

Zura Bio Analyst Ratings

ズラバイオアナリストレーティング

Benzinga ·  2023/08/25 03:06
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/25/2023 151.85% Oppenheimer → $17 Initiates Coverage On → Outperform
08/15/2023 225.93% Raymond James $20 → $22 Maintains Strong Buy
06/22/2023 196.3% Guggenheim → $20 Initiates Coverage On → Buy
06/14/2023 107.41% Chardan Capital → $14 Initiates Coverage On → Buy
05/24/2023 196.3% Raymond James → $20 Initiates Coverage On → Strong Buy

What is the target price for Zura Bio (ZURA)?

The latest price target for Zura Bio (NASDAQ: ZURA) was reported by Oppenheimer on August 25, 2023. The analyst firm set a price target for $17.00 expecting ZURA to rise to within 12 months (a possible 151.85% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Zura Bio (ZURA)?

The latest analyst rating for Zura Bio (NASDAQ: ZURA) was provided by Oppenheimer, and Zura Bio initiated their outperform rating.

When is the next analyst rating going to be posted or updated for Zura Bio (ZURA)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zura Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zura Bio was filed on August 25, 2023 so you should expect the next rating to be made available sometime around August 25, 2024.

Is the Analyst Rating Zura Bio (ZURA) correct?

While ratings are subjective and will change, the latest Zura Bio (ZURA) rating was a initiated with a price target of $0.00 to $17.00. The current price Zura Bio (ZURA) is trading at is $6.75, which is within the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする